Wedbush Securities’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Wedbush Securities’s Portfolio VCNX Stock Details VCNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-148	Closed	-$55K	–	995
2020 Q3	$55K	Buy	+148	New	+$161K	0.01%	876

Other funds holding VCNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Tacita Capital Toronto, Ontario, Canada $184M AUM 26.11% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Wedbush Securities's VCNX Position: Q4 2020 in Review

Wedbush Securities sold out of Vaccinex, Inc. Common Stock (VCNX) in Q4 2020, closing a stake of 148 shares — an estimated $55K sold.

Wedbush Securities first reported a position in VCNX in Q3 2020 and held it in 1 quarter. The position peaked at $55K in Q3 2020. 18 funds tracked by Wall St. Rank hold VCNX as of Q4 2020.

Wedbush Securities reported no remaining Vaccinex, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Wedbush Securities sold 148 Vaccinex, Inc. Common Stock shares in Q4 2020, an estimated $55K.
Wedbush Securities first reported a position in Vaccinex, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
Wedbush Securities's Vaccinex, Inc. Common Stock position peaked at $55K in Q3 2020.
18 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q4 2020.

Based on Wedbush Securities's 13F filing for Q4 2020, filed 16 Feb 2021.